Imperial College London

ProfessorKatharinaHauck

Faculty of MedicineSchool of Public Health

Professor in Health Economics
 
 
 
//

Contact

 

+44 (0)20 7594 9197k.hauck Website

 
 
//

Assistant

 

Ms Julie Middleton +44 (0)20 7594 3284

 
//

Location

 

Office 502School of Public HealthWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Daunt:2020:10.1016/j.jinf.2020.06.049,
author = {Daunt, A and Perez-Guzman, PN and Liew, F and Hauck, K and Costelloe, CE and Thursz, MR and Cooke, G and Nayagam, S},
doi = {10.1016/j.jinf.2020.06.049},
journal = {Journal of Infection},
pages = {666--668},
title = {Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease},
url = {http://dx.doi.org/10.1016/j.jinf.2020.06.049},
volume = {81},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Daunt,A
AU - Perez-Guzman,PN
AU - Liew,F
AU - Hauck,K
AU - Costelloe,CE
AU - Thursz,MR
AU - Cooke,G
AU - Nayagam,S
DO - 10.1016/j.jinf.2020.06.049
EP - 668
PY - 2020///
SN - 0163-4453
SP - 666
TI - Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease
T2 - Journal of Infection
UR - http://dx.doi.org/10.1016/j.jinf.2020.06.049
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000574392800037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://www.sciencedirect.com/science/article/pii/S0163445320304308?via%3Dihub
UR - http://hdl.handle.net/10044/1/87414
VL - 81
ER -